Income statement revenue $390.05M (+14.9% YoY).Operating income $41.04M (+0.5% YoY).Pre-tax result $46.19M (+1.9% YoY).Net result $34.81M (-23.1% YoY).

Thrombectomy: $258.98M (+12.5% YoY)
Embolization And Access: $131.07M (+20.0% YoY)
Research and development: $25.4M (+9.4% YoY)
Sales, general and administrative: $198.51M (+24.1% YoY)
Other income: $5.15M (+14.9% YoY)
Income tax expense: $11.38M (+28340.0% YoY)

Loading financials

Income statement income statement flow. Revenue $390.05M. Net result $34.81M.

Income statement revenue $390.05M (+14.9% YoY).Operating income $41.04M (+0.5% YoY).Pre-tax result $46.19M (+1.9% YoY).Net result $34.81M (-23.1% YoY).

Thrombectomy: $258.98M (+12.5% YoY)
Embolization And Access: $131.07M (+20.0% YoY)
Research and development: $25.4M (+9.4% YoY)
Sales, general and administrative: $198.51M (+24.1% YoY)
Other income: $5.15M (+14.9% YoY)
Income tax expense: $11.38M (+28340.0% YoY)